GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent: Cross-Presentation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002479 describes the TAP-dependent cross-presentation pathway in which exogenous antigens are degraded and their peptides are transported by TAP into the ER for loading onto MHC class I molecules [1,5].
• This process is essential for CD8+ T cell priming against viruses and tumors that do not infect or originate in professional antigen-presenting cells [5,6].
• Dendritic cells are the primary cells capable of TAP-dependent cross-presentation, and cytokines such as GM-CSF and IL-4 regulate this pathway.
• TAP-mediated processing of exogenous antigens is required for protective immunity, as shown for radiation-attenuated Plasmodium sporozoites.
• Bacteria can induce neo-biosynthesis and surface expression of functional class I molecules in dendritic cells, linking infection to enhanced cross-presentation.
• Experimental dissection of this pathway uses knockout, point-mutation, knock-in, and overexpression models to test the role of TAP, MHC class I, and associated genes [1,2,5].
Description
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479) is a specialized biological process, often called cross-presentation, in which an antigen-presenting cell takes up exogenous proteins, degrades them, and presents the resulting peptides on MHC class I molecules in a manner that requires the transporter associated with antigen processing (TAP) [1,5]. This pathway allows CD8+ T cells to recognize antigens that are not synthesized within the presenting cell, which is critical for immunity against viruses that do not infect dendritic cells and against tumors [5,6]. The term is defined in QuickGO as the process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP pathway. The peptide is typically a fragment of a larger exogenous protein that has been degraded within the cell and is dependent on TAP transport from the cytosol to the endoplasmic reticulum (ER) for association with the MHC class I molecule [1,5]. Researchers study GO:0002479 to understand how the immune system detects extracellular pathogens and tumors, and to design vaccines and immunotherapies that exploit cross-presentation [2,5]. The pathway is experimentally tractable using dendritic cell models, TAP-deficient cells, and CRISPR-based genetic screens [1,2,6].
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent At A Glance
| GO ID | GO:0002479 |
|---|---|
| GO term | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
| Ontology | biological_process |
| Synonym | cross presentation; cross-presentation; exogenous peptide antigen processing and presentation via MHC class I, TAP-dependent; TAP-dependent antigen processing and presentation of exogenous peptide antigen via MHC class I; TAP-dependent exogenous peptide antigen processing and presentation via MHC class I |
| Major function | Presentation of exogenous peptides on MHC class I molecules to CD8+ T cells in a TAP-dependent manner [1,5] |
| Cellular location | Endosomes, cytosol, endoplasmic reticulum, and cell surface [1,5] |
| Key transporter | TAP (transporter associated with antigen processing) [1,2] |
| Primary cell type | Dendritic cells and other professional antigen-presenting cells [5,6] |
| Regulation | Cytokines such as GM-CSF and IL-4 modulate the pathway |
What Is GO:0002479?
GO:0002479 is the biological process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein that has been degraded within the cell and is dependent on TAP transport from the cytosol to the ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. Synonyms include cross presentation, cross-presentation, exogenous peptide antigen processing and presentation via MHC class I, TAP-dependent, TAP-dependent antigen processing and presentation of exogenous peptide antigen via MHC class I, and TAP-dependent exogenous peptide antigen processing and presentation via MHC class I.
Why Is antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Important in Cell Biology?
GO:0002479 is important because it enables the immune system to detect and respond to exogenous threats, including viruses and tumors, through CD8+ T cell activation [5,6]. This pathway is essential for protective immunity induced by certain vaccines, as demonstrated by the requirement for TAP-mediated processing of exoerythrocytic antigens in radiation-attenuated Plasmodium sporozoite vaccination. Defects in cross-presentation can lead to impaired immune surveillance, while overactivation may contribute to autoimmunity. Understanding the molecular players and regulatory mechanisms of this process is therefore critical for vaccine development, cancer immunotherapy, and the treatment of infectious diseases [2,5].
• Enables CD8+ T cell priming against viruses that do not infect dendritic cells.
• Critical for antitumor immunity by presenting tumor-associated exogenous antigens [5,6].
• Required for protective immunity induced by radiation-attenuated Plasmodium sporozoites.
• Regulated by cytokines such as GM-CSF and IL-4, linking innate signals to adaptive immunity.
• Bacteria can enhance class I molecule biosynthesis and surface expression in dendritic cells, boosting cross-presentation.
• Provides a mechanism for immune surveillance of extracellular pathogens and their products [1,4].
• Involved in the development of vaccines that target cross-presentation pathways.
• Dysregulation may contribute to autoimmune diseases or tumor immune evasion.
• Serves as a target for experimental immunotherapies using CRISPR screens [1,2].
• Key model for studying antigen trafficking and MHC class I loading [1,5].
What Happens During antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent?
Uptake and degradation of exogenous antigen
In simple terms: The cell swallows foreign proteins and chops them into small pieces.
Antigen-presenting cells such as dendritic cells internalize exogenous proteins through phagocytosis, macropinocytosis, or receptor-mediated endocytosis. These proteins are then degraded within endosomes and lysosomes, generating peptide fragments that can be further processed in the cytosol [1,5]. Studies using phage particle antigens have shown that cross-presentation occurs in MHC class II and endoplasmic reticulum marker-positive compartments, indicating that exogenous antigens are delivered to specialized intracellular compartments for processing.
TAP-dependent transport of peptides into the ER
In simple terms: A molecular pump called TAP carries the peptide pieces into a compartment where they can meet MHC class I.
After degradation, peptides are transported from the cytosol into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP). This step is essential for loading peptides onto MHC class I molecules. The requirement for TAP in processing exogenous antigens has been demonstrated in models of Plasmodium infection, where TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated sporozoites. TAP deficiency abolishes cross-presentation, confirming the TAP-dependent nature of this pathway [1,2].
Loading of peptide onto MHC class I and surface presentation
In simple terms: The peptide is loaded onto an MHC class I molecule, which then travels to the cell surface to show it to immune cells.
In the ER, the transported peptide binds to the groove of newly synthesized MHC class I heavy chain and beta-2-microglobulin. This peptide-MHC class I complex then travels through the secretory pathway to the cell surface, where it is presented to CD8+ T cells. Dendritic cells can present exogenous protein antigens on MHC class I molecules through this pathway, and the process is regulated by cytokines such as GM-CSF and IL-4. Bacteria-induced neo-biosynthesis and stabilization of class I molecules in mouse dendritic cells further enhance surface expression of functional class I molecules, facilitating cross-presentation.
Alternative class I-restricted presentation pathways
In simple terms: There are other ways to present exogenous antigens, but this GO term specifically covers the TAP-dependent route.
Evidence for an alternative class I-restricted antigen presentation pathway that sensitizes MHC class I-restricted T cells to exogenous proteins has been reported, but GO:0002479 specifically refers to the TAP-dependent mechanism. The TAP-dependent pathway is distinguished by its requirement for proteasomal degradation and TAP-mediated transport, whereas TAP-independent pathways may involve different intracellular compartments [1,4].
Key Genes Involved in GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
The following genes and proteins are central to the TAP-dependent cross-presentation pathway described by GO:0002479.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TAP1 | Subunit of the TAP transporter that pumps peptides into the ER | Knockout abolishes cross-presentation; target for functional studies [1,2] |
| TAP2 | Subunit of the TAP transporter; forms a heterodimer with TAP1 | Essential for peptide transport; mutations affect antigen presentation [1,2] |
| HLA-A | Classical MHC class I heavy chain that presents peptides to CD8+ T cells | Polymorphisms influence peptide binding and immune responses |
| HLA-B | Classical MHC class I heavy chain | Key for presenting viral and tumor antigens |
| HLA-C | Classical MHC class I heavy chain | Modulates NK cell and T cell responses |
| B2M | Beta-2-microglobulin; light chain of MHC class I | Knockout eliminates surface MHC class I expression [5,6] |
| PSMB8 | Immunoproteasome subunit that generates peptides for MHC class I | Influences peptide repertoire for cross-presentation |
| PSMB9 | Immunoproteasome subunit | Enhances generation of TAP-transportable peptides |
| PSMB10 | Immunoproteasome subunit | Contributes to peptide processing |
| TAPBP | Tapasin; bridges TAP and MHC class I for peptide loading | Required for efficient peptide loading |
| CALR | Calreticulin; chaperone in MHC class I assembly | Supports peptide loading complex |
| CANX | Calnexin; chaperone for MHC class I folding | Quality control of MHC class I |
| PDIA3 | ERp57; oxidoreductase in peptide loading complex | Facilitates disulfide bond formation |
| SEC61A1 | Core component of the Sec61 translocon | Involved in peptide transport into ER |
| DERL1 | Derlin-1; retrotranslocation of misfolded proteins | May influence antigen delivery to cytosol |
| LAMP1 | Lysosomal-associated membrane protein 1 | Marker of endosomal compartments in cross-presentation |
| RAB3B | Small GTPase involved in vesicular trafficking | Regulates endosomal transport |
| RAB7A | Late endosomal GTPase | Controls phagosome maturation |
How Is antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Regulated?
The TAP-dependent cross-presentation pathway is regulated at multiple levels. Cytokines such as GM-CSF and IL-4 enhance the presentation of exogenous protein antigens on MHC class I molecules by dendritic cells. Bacterial stimulation induces neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells, thereby boosting cross-presentation capacity. Additionally, the pathway is influenced by the availability of TAP and proteasome components, and by intracellular trafficking regulators such as Rab GTPases. The process is also dependent on the ER-resident peptide loading complex, including tapasin, calreticulin, and ERp57.
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TAP1 | Immune evasion in tumors; susceptibility to viral infections | TAP1 knockout dendritic cells or mice [1,2] |
| TAP2 | Impaired antigen presentation; bacterial infections | TAP2 point-mutation knock-in [1,2] |
| B2M | Loss of MHC class I surface expression in cancer | B2M knockout tumor cell lines [5,6] |
| HLA-A | Autoimmunity and cancer immunotherapy response | HLA-A transgenic or knock-in models |
| PSMB8 | Immunoproteasome dysfunction; autoinflammation | PSMB8 knockout or point-mutation models |
Cancer immunotherapy
TAP-dependent cross-presentation is critical for priming CD8+ T cell responses against tumor antigens. Defects in this pathway can lead to immune evasion by tumors. Experimental models using dendritic cells and TAP-deficient mice have shown that cross-presentation is required for effective antitumor immunity [5,6].
Infectious diseases
Protective immunity against pathogens such as Plasmodium depends on TAP-mediated processing of exogenous antigens. Radiation-attenuated sporozoite vaccines require TAP for inducing protection, highlighting the importance of this pathway in vaccine development. Similarly, bacterial infections can enhance class I molecule expression and cross-presentation in dendritic cells.
Autoimmunity
Dysregulated cross-presentation may contribute to the activation of autoreactive CD8+ T cells. While direct evidence is limited, the pathway is a potential target for modulating autoimmune responses.
From antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TAP1 required for cross-presentation of a specific antigen? | TAP1 knockout dendritic cell line or mouse [1,2] |
| Does a point mutation in TAP2 affect peptide transport? | TAP2 point-mutation knock-in via CRISPR [1,2] |
| Can overexpression of TAP1 enhance cross-presentation? | TAP1 overexpression in dendritic cells |
| What is the role of B2M in surface MHC class I expression? | B2M knockout cells [5,6] |
| How does a tagged TAP1 behave in live cells? | TAP1 tagged knock-in with fluorescent protein |
| Which genes regulate cross-presentation? | CRISPR library screening in dendritic cells [1,2] |
How to Study the antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with tetramers | Antigen-specific CD8+ T cell activation | Quantify cross-presentation efficiency |
| CRISPR knockout screen | Genes required for cross-presentation | Identify novel regulators [1,2] |
| Immunopeptidomics | Peptides presented on MHC class I | Validate TAP-dependent peptide repertoire [1,5] |
| Confocal microscopy | Intracellular localization of antigens and MHC class I | Track trafficking to ER compartments |
| TAP transport assay | Peptide translocation into ER | Measure TAP function [1,2] |
| qRT-PCR | Expression of TAP1, TAP2, and MHC class I genes | Assess regulation by cytokines |
| Western blot | Protein levels of TAP and MHC class I | Confirm knockout or overexpression [5,6] |
| ELISPOT | Cytokine secretion by activated T cells | Functional readout of cross-presentation |
Flow cytometry and MHC class I tetramers
Flow cytometry using peptide-MHC class I tetramers allows quantification of antigen-specific CD8+ T cell activation following cross-presentation. This method is widely used to assess the efficiency of TAP-dependent presentation in dendritic cells [5,6].
CRISPR knockout screens
Genome-wide CRISPR knockout screens in dendritic cells or antigen-presenting cell lines can identify genes required for TAP-dependent cross-presentation. Hits often include TAP1, TAP2, and proteasome subunits [1,2].
Proteomics and immunopeptidomics
Mass spectrometry-based immunopeptidomics can identify peptides presented on MHC class I molecules derived from exogenous antigens. This approach validates the TAP-dependent pathway and reveals the peptide repertoire [1,5].
Imaging of intracellular trafficking
Confocal microscopy and live-cell imaging using fluorescently tagged TAP, MHC class I, and endosomal markers can visualize the transport of exogenous antigens to ER-positive compartments.
How CRISPR Can Be Used to Study GO:0002479 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
Knockout
CRISPR knockout of TAP1, TAP2, or B2M in dendritic cells or tumor cell lines abolishes TAP-dependent cross-presentation, providing a clean negative control. These models are used to confirm the requirement for specific genes in the pathway [1,2,5].
Point Mutation
Point mutations in TAP1 or TAP2 can be introduced to mimic human polymorphisms or to dissect the ATP-binding and peptide-translocation functions of the transporter. Such models help determine which residues are critical for TAP-dependent antigen processing [1,2].
Knock-in
Knock-in of tagged versions of TAP1, TAP2, or MHC class I heavy chains (e.g., with fluorescent or affinity tags) allows real-time tracking of the cross-presentation machinery in live cells. This approach is valuable for imaging and proteomic studies.
Overexpression
Overexpression of TAP1, TAP2, or immunoproteasome subunits in antigen-presenting cells can enhance cross-presentation efficiency. This strategy is used to boost vaccine-induced CD8+ T cell responses in experimental models [5,6].
How EDITGENE Supports antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent Research
Researchers studying antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent-related genes often need to determine whether a candidate gene is causally involved in cross-presentation, whether a specific mutation alters TAP function, or whether overexpression enhances immune activation. EDITGENE provides the full spectrum of CRISPR-engineered cell models to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IKBKB Knockout HEK293 Cell Line | EDJ-KQ566 | Human | 3551 | Details Get a Quote |
| PSMB10 Knockout HEK293 Cell Line | EDJ-KQ1927 | Human | 5699 | Details Get a Quote |
| IKBKB Knockout A-549 Cell Line | EDJ-KQ18953 | Human | 3551 | Details Get a Quote |
| IKBKB Knockout HCT 116 Cell Line | EDJ-KQ18954 | Human | 3551 | Details Get a Quote |
| IKBKB Knockout HeLa Cell Line | EDJ-KQ18955 | Human | 3551 | Details Get a Quote |
| PSMB10 Knockout A-549 Cell Line | EDJ-KQ23219 | Human | 5699 | Details Get a Quote |
| PSMB10 Knockout HCT 116 Cell Line | EDJ-KQ23221 | Human | 5699 | Details Get a Quote |
| PSMB10 Knockout HeLa Cell Line | EDJ-KQ23222 | Human | 5699 | Details Get a Quote |
| PSMB10 Knockout HAP1 Cell Line | EDC08303 | Human | 5699 | Details Get a Quote |
Displaying Records 1 To 9 Of 9 Records
Frequently Asked Questions About antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
What is GO:0002479?
GO:0002479 is the biological process of antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent, also known as cross-presentation. It allows antigen-presenting cells to present exogenous peptides on MHC class I molecules to CD8+ T cells [1,5].
What genes are involved in antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent?
Key genes include TAP1, TAP2, B2M, HLA-A, HLA-B, HLA-C, PSMB8, PSMB9, PSMB10, TAPBP, CALR, CANX, and PDIA3 [1,2,5].
Why is TAP important for cross-presentation?
TAP transports degraded exogenous peptides from the cytosol into the endoplasmic reticulum, where they can be loaded onto MHC class I molecules. Without TAP, cross-presentation is abolished [1,2].
Which cells perform TAP-dependent cross-presentation?
Dendritic cells are the primary cells capable of TAP-dependent cross-presentation, although other professional antigen-presenting cells may also contribute [5,6].
How is cross-presentation regulated?
Cytokines such as GM-CSF and IL-4 enhance cross-presentation, and bacterial stimulation can induce neo-biosynthesis of MHC class I molecules in dendritic cells [5,6].
What diseases are associated with defects in TAP-dependent cross-presentation?
Defects can lead to impaired immunity against viruses and tumors, and may affect vaccine efficacy. The pathway is also relevant to autoimmunity [2,5].
What experimental models are used to study GO:0002479?
Common models include TAP1 or TAP2 knockout mice and dendritic cell lines, B2M knockout cells, and CRISPR knock-in of tagged MHC class I or TAP subunits [1,2,5].
How can CRISPR help study TAP-dependent cross-presentation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes like TAP1, TAP2, and B2M to test their roles in cross-presentation [1,2,5].
What is the difference between cross-presentation and direct presentation?
Direct presentation involves MHC class I loading with endogenous peptides, while cross-presentation (GO:0002479) involves exogenous antigens that are processed and loaded in a TAP-dependent manner [1,5].
What methods measure TAP-dependent cross-presentation?
Flow cytometry with peptide-MHC tetramers, ELISPOT, immunopeptidomics, and TAP transport assays are commonly used [1,2,5].
Conclusion
GO:0002479 describes a vital immune mechanism that enables CD8+ T cell responses against exogenous antigens, including those from viruses and tumors. The TAP-dependent cross-presentation pathway is essential for protective immunity and is a key target for vaccine and immunotherapy development [2,5]. Understanding its molecular players and regulation through CRISPR-based models will continue to advance both basic immunology and clinical applications.
References
- 1. Wan Y et al.. 2005. Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.. Eur J Immunol 35(7):2041-50 PMID: 15940671
- 2. Pichugin A et al.. 2016. TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites.. Eur J Immunol 46(4):885-96 PMID: 26703789
- 4. Martinez-Kinader B et al.. 1995. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.. Immunology 86(2):287-95 PMID: 7490131
- 5. Brossart P et al.. 1997. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.. Blood 90(4):1594-9 PMID: 9269778
- 6. Rescigno M et al.. 1998. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.. Proc Natl Acad Sci U S A 95(9):5229-34 PMID: 9560258
